DRGI
TEVA icon

del Rey Global Investors’s Teva Pharmaceuticals TEVA Stock Holding History

del Rey Global Investors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$2.01M Sell
50,123
-85,594
-63% -$3.37M 6.61% 5
2013
Q3 		$5.13M Buy
135,717
+10,310
+8% +$402K 8.1% 6
2013
Q2 		$4.92M Buy
+125,407
New +$4.88M 8.77% 7

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

del Rey Global Investors's TEVA Position: Q4 2013 in Review

del Rey Global Investors reduced its Teva Pharmaceuticals (TEVA) stake by 63% in Q4 2013, selling an estimated $3.37M and leaving 50,123 shares worth $2.01M. The position accounts for 6.61% of the portfolio, ranked #5.

del Rey Global Investors first reported a position in TEVA in Q2 2013 and has held it in 3 quarters since. The position peaked at $5.13M in Q3 2013. 728 funds tracked by Wall St. Rank hold TEVA as of Q4 2013.

  • del Rey Global Investors held 50,123 shares of Teva Pharmaceuticals worth $2.01M as of Q4 2013.
  • del Rey Global Investors sold 85,594 Teva Pharmaceuticals shares in Q4 2013, an estimated $3.37M.
  • Teva Pharmaceuticals made up 6.61% of del Rey Global Investors's portfolio in Q4 2013, its #5 holding.
  • del Rey Global Investors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 3 quarters since.
  • del Rey Global Investors's Teva Pharmaceuticals position peaked at $5.13M in Q3 2013.
  • 728 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2013.

Based on del Rey Global Investors's 13F filing for Q4 2013, filed 14 Feb 2014.